DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Fluazacort

Fluazacort

  • Nitrate Prodrugs Able to Release Nitric Oxide in a Controlled and Selective

    Nitrate Prodrugs Able to Release Nitric Oxide in a Controlled and Selective

  • )&F1y3x PHARMACEUTICAL APPENDIX to THE

    )&F1y3x PHARMACEUTICAL APPENDIX to THE

  • Partial Agreement in the Social and Public Health Field

    Partial Agreement in the Social and Public Health Field

  • Pharmaceuticals Appendix

    Pharmaceuticals Appendix

  • Pharmaceutical Appendix to the Tariff Schedule 2

    Pharmaceutical Appendix to the Tariff Schedule 2

  • (12) United States Patent (10) Patent No.: US 7,544,192 B2 Eaton Et Al

    (12) United States Patent (10) Patent No.: US 7,544,192 B2 Eaton Et Al

  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

    Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

  • Formulation for Controlled Release of Drugs by Combining Hydrophilic And

    Formulation for Controlled Release of Drugs by Combining Hydrophilic And

  • Wo 2008/127291 A2

    Wo 2008/127291 A2

  • Stembook 2018.Pdf

    Stembook 2018.Pdf

  • Ep 2301628 A1

    Ep 2301628 A1

  • Compositions, Methods and Devices for Generating Nanotubes on a Surface

    Compositions, Methods and Devices for Generating Nanotubes on a Surface

  • Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes

    Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes

  • (12) United States Patent (Lo) Patent No.: �US 8,480,637 B2

    (12) United States Patent (Lo) Patent No.: US 8,480,637 B2

  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs

    Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs

  • Guide to the Syntex Collection of Pharmaceutical Advertising

    Guide to the Syntex Collection of Pharmaceutical Advertising

  • (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al

    (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al

  • Sinus Delivery of Sustained Release Therapeutics

    Sinus Delivery of Sustained Release Therapeutics

Top View
  • (12) United States Patent (10) Patent No.: US 8,080,553 B2 Keith Et Al
  • Transdermal Device Containing
  • Use of Prodrugs for Ocular Intravitreous Administration
  • Customs Tariff - Schedule Xxi - 1
  • (12) United States Patent (10) Patent No.: US 9,526,824 B2 Ferrari Et Al
  • Wo 2007/044693 A2
  • (12) United States Patent (10) Patent No.: US 8.258,153 B2 Chappell Et Al
  • WO 2015/167760 Al 5 November 2015 (05.11.2015) P O P C T
  • Harmonized Tariff Schedule of the United States (2006) (Rev
  • The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
  • (12) United States Patent (10) Patent No.: US 8,480,637 B2 Ferrari Et Al
  • Ep 2216026 B1
  • Use of Prodrugs for Ocular Intravitreous Administration
  • The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
  • (12) Patent Application Publication (10) Pub. No.: US 2015/0335707 A1 Swamynathan Et Al
  • Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
  • 1111111111111111111Imnumu
  • Pharmaceuticals Appendix


© 2024 Docslib.org    Feedback